🇺🇸 FDA
Pipeline program

Ertapenem

IT001-303

Phase 3 small_molecule completed

Quick answer

Ertapenem for Intra Abdominal Infections is a Phase 3 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Iterum Therapeutics plc
Indication
Intra Abdominal Infections
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials